Key facts
as of Oct 2026- Developer of digital respiratory care tools designed to facilitate automated self-management and clinical monitoring for chronic lung conditions.
- MediTuner is valued at approximately $13.1M as of Oct 2026 (last reported valuation).
- It has raised $8.5M; the latest was Later Stage VC ($2.1M) in Dec 2024.
- Notable investors include Almi Invest, Nordic Mentor Network For Entrepreneurship, Butterfly Ventures, California Life Sciences, DRIVE ( KI Innovations Business Incubator) — 10 tracked in total.
- Status: Privately Held (backing).
Last reported valuation
LOW confidence$13.1M
MediTuner's last reported valuation, Dec 2024. Nothing priced has surfaced since.
Free account
More of MediTuner with a free account
- ·Watch MediTuner: the Monday email on marks, rounds and moves
Create free account
No card required
Funding rounds
No rounds on record
No funding rounds for MediTuner are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
About MediTuner
Developer of digital respiratory care tools designed to facilitate automated self-management and clinical monitoring for chronic lung conditions. The company offers a mobile application that tracks inhalation technique and lung function via an electronic spirometer while providing automated medication adjustments and real-time data sharing with healthcare professionals through a web portal, enabling asthma patients to receive precise clinical guidance and improved control over their respiratory health.
- Sector
- Healthcare
- HQ
- Ramsey, MN, United States
- Founded
- 2014
- Employees
- 24
- Website
- medituner.com/
- Ownership
- Privately Held (backing)